Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
Become a Member | Sign in
Home>News>This Article

Boehringer Ingelheim Implements Titian’s Mosaic Software

Published: Tuesday, September 17, 2013
Last Updated: Tuesday, September 17, 2013
Bookmark and Share
Mosaic™ sample management software to manage New Biological Entity samples.

Titian Software has announced that Boehringer Ingelheim has implemented its Mosaic™ sample management software for the inventory management, sample tracking, and sample processing of New Biological Entities (NBE).

Now well-established as a leading provider of sample management software for small molecule compound libraries, Titian has evolved Mosaic into enterprise-wide management of biological samples, reagents and standards.

The new installation has Boehringer Ingelheim incorporating Mosaic into their protein purification, gene expression, biological lead engineering, and biological lead generation workflows within the NBE groups.

Titian CEO, Edmund Wilson said: “Drug discovery is now more challenging than ever, and so pharmaceutical, biotech and academic organizations are seeking to maximize the efficiencies of their laboratory processes. Knowing where a sample is, what its character make-up is, and what has been done to it and by whom, is an essential element in this efficiency. Mosaic’s success has been built on the premise of listening to the needs of customers in various organizations. Based on this we have developed Mosaic to cover biological applications in addition to our heartland of chemical sample management, for which we are recognized as the ‘go-to’ offering.”

Mr Wilson continued: “We are delighted to announce this project with Boehringer Ingelheim which reflects Mosaic’s success with the management of biological samples.”

Mosaic is a modular software suite, providing a range of flexible options for many different types and sizes of life science research organizations in industry and academia.

Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,200+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Scientists Uncover Why Hepatitis C Vaccine is Difficult to Make
Scientists have uncovered one reason why a successful hepatitis C vaccine continues to be elusive.
Antibodies from Ebola Survivors Neutralize Virus, Protect Lab Mice
Scientists discover antiboides generated from the blood of Ebola survivors can strongly combat the virus in the lab.
Gene Editing Corrects Sickle Cell Mutation
Researchers demonstrate a potential pathway to developing gene-editing treatments for sickle cell disease.
Sustained SIV Remission Achieved in Monkeys
Experimental treatment boosts monkey immune system to force SIV into sustained remission.
Fighting Cancer with Immune Response
New treatment elicits two-pronged immune response that destroys tumors in mice.
Nanoparticles Offer Promising Platform for Flavivirus Treatment
New nanoparticle effectively vaccinated mice against one dengue strain and could be created to target all four.
Overlooked Molecules Could Revolutionise our Understanding of the Immune System
Researchers have discovered that around one third of all the epitopes displayed for scanning by the immune system are a type known as ‘spliced’ epitopes.
Signaling Pathway Could Be Key to Improved Osteoporosis Treatment
Inhibition of SIK2 enzyme both stimulates bone formation and reduces bone breakdown in animal model.
Less Frequent Cervical Cancer Screening
HPV-vaccinated women may only need one screening every 5 to 10 years with screening starting later in life.
The Power Of Orthogonality In Assessing The Stability Of Biopharmaceuticals
By utilizing orthogonal techniques, researchers can maximize the secure application of all analytical results generated.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,200+ scientific videos